Financial Statements · Financial Reporting

Narafarm OÜ

Official identifier 12139312Record date 31 Dec 2023
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2023
Period start
1 Jan 2023
Submitted date
27 Jun 2024

Report

Consolidated
No
Audited
No

Financial metrics

StatementMetricValue
Bilanss, detailneAssets1,037,515
Bilanss, detailneCash and cash equivalents30,874
Bilanss, detailneCurrent assets184,187
Bilanss, detailneCurrent liabilities131,328
Bilanss, detailneEquity608,246
Bilanss, detailneShare capital at nominal value2,500
Bilanss, detailneNon-current assets853,328
Bilanss, detailneNon-current liabilities297,941
Bilanss, detailneRetained earnings (loss) from previous periods602,853
Income statement scheme 1Depreciation and impairment of non-current assets-103,164
Income statement scheme 1Labour costs-24,304
Income statement scheme 1Revenue263,951
Income statement scheme 1Annual period profit / loss2,643
Income statement scheme 1Operating profit (loss)27,040
Income statement scheme 1Profit (loss) before income tax2,643
Profit distribution proposalRetained earnings (loss) from previous periods602,853
Note: Labour costsEmployees2
Note: Labour costsLabour costs24,304

Linked company

Company: Narafarm OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements